Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q77899300)
Watch
English
Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker
scientific article published on 01 November 1998
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9916605
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 December 2019
title
Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9916605
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 December 2019
author
Suzanne Oparil
series ordinal
2
object named as
S Oparil
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9916605
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 December 2019
author name string
J Pool
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9916605
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 December 2019
T Hedner
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9916605
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 December 2019
R Glazer
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9916605
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 December 2019
P Oddou-Stock
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9916605
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 December 2019
A Hester
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9916605
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 December 2019
publication date
1 November 1998
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9916605
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 December 2019
published in
Clinical Therapeutics
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9916605
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 December 2019
volume
20
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9916605
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 December 2019
issue
6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9916605
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 December 2019
page(s)
1106-1114
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9916605
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 December 2019
cites work
Antihypertensive therapy in the era of evidence based medical practice: what to do until the facts are in
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Compliance with antihypertensive treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose-response relationships with antihypertensive drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New therapeutic agents in the management of hypertension: angiotensin II-receptor antagonists and renin inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Valsartan. A review of its pharmacology and therapeutic use in essential hypertension
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety of irbesartan in the treatment of mild to moderate systemic hypertension
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The antihypertensive effect and tolerability of candesartan cilexetil, a new generation angiotensin II antagonist, in comparison with losartan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical safety and tolerability of losartan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose-related efficacy of irbesartan for hypertension: an integrated analysis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Binding of valsartan to mammalian angiotensin AT1 receptors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared to hydrochlorothiazide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Blood pressure lowering for the secondary prevention of myocardial infarction and stroke
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Large-scale randomized evidence: large, simple trials and overviews of trials.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and tolerability of valsartan in combination with hydrochlorothiazide in essential hypertension
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980107-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0149-2918(98)80107-0
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9916605
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 December 2019
PubMed publication ID
9916605
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9916605
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit